This bill establishes regulations regarding the distribution of gene-based vaccines in Iowa, defining key terms such as "deoxyribonucleic acid contamination," "distribute," "gene-based vaccine," "shedding," and "transmission." It mandates that manufacturers conduct studies on transmissibility, contamination, and shedding before distributing these vaccines within the state. Additionally, it imposes penalties on individuals who distribute gene-based vaccines that pose an unreasonable risk to public health, as determined by the FDA, with fines of $1,000 per occurrence and potential licensing discipline.

Furthermore, the bill clarifies that manufacturers are not immune from liability for injuries or deaths resulting from design defects in gene-based vaccines. It also instructs the Department of Inspections, Appeals, and Licensing to create rules for the enforcement and administration of these provisions. Overall, the legislation aims to enhance safety and accountability in the distribution of gene-based vaccines.